Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Surmodics Inc (NQ: SRDX )

19.02 +0.79 (+4.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 80,921
Open 18.53
Bid (Size) 14.09 (2)
Ask (Size) 28.82 (1)
Prev. Close 18.23
Today's Range 18.36 - 19.03
52wk Range 16.00 - 39.99
Shares Outstanding 14,134,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 5 Health Care Stocks That Could Blast Off In May
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Surmodics to Participate in the Jefferies Healthcare Conference on June 8
From Surmodics, Inc.
Via Business Wire

Performance

YTD
-43.41%
-43.41%
1 Month
-17.38%
-17.38%
3 Month
-17.88%
-17.88%
6 Month
-47.15%
-47.15%
1 Year
-51.97%
-51.97%

More News

Read More
Surmodics's Return on Invested Capital Insights
Via Benzinga
Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
From Surmodics, Inc.
Via Business Wire
Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System
From Surmodics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Surmodics to Report Second Quarter of Fiscal 2023 Financial Results on April 26
From Surmodics, Inc.
Via Business Wire
Surmodics Announces Successful First Patient Use of Sublime™ Radial Access Microcatheter Designed for the Periphery
From Surmodics, Inc.
Via Business Wire
Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20
From Surmodics, Inc.
Via Business Wire
Surmodics, Inc. (NASDAQ:SRDX) Shareholder Alert: Investigation Concerning Possible Wrongdoing
Via SBWire
Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
From Surmodics, Inc.
Via Business Wire
Sidoti's Small-Cap Virtual March Conference
Via ACCESSWIRE
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
Via NewMediaWire
Exposures Product Safety
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
Via NewMediaWire
Exposures Product Safety
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX
From The Rosen Law Firm PA
Via GlobeNewswire
Surmodics to Participate in Upcoming Investor Conferences in March
From Surmodics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
NATIONALLY RANKED ROSEN LAW FIRM Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
Via NewMediaWire
Exposures Product Safety
SRDX NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
Via NewMediaWire
Exposures Product Safety
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX
From The Rosen Law Firm PA
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
ROSEN, A LEADING LAW FIRM, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
Via NewMediaWire
Exposures Product Safety
Abbott-Cardiovascular Systems Acquisition Could Further Add Uncertainty Over Surmodics' Product: Analyst Downgrades Stock
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.